Help Advance Myasthenia Gravis Research
Clinical trials and research studies play an important role in advancing treatment options for myasthenia gravis (MG). Many of today’s therapies are available because people living with MG chose to participate in research.
If you’re interested in learning about clinical trials, research studies, or other opportunities to contribute to MG research, this page can help you get started.
Participation in research is always voluntary. Before deciding whether a clinical trial or research study is right for you, we encourage you to discuss the opportunity with your healthcare provider.
Please note: Conquer MG shares these opportunities for informational purposes only and does not endorse any specific study, treatment, therapy, or organization. Participation is always voluntary, and we encourage you to discuss any opportunity with your healthcare provider.
Find Clinical Trials
National Search Resources
Current Research Opportunities
The following research opportunities have been shared with Conquer MG by study sponsors or research organizations. Conquer MG shares these opportunities for educational purposes only and does not endorse any specific study, treatment, or therapy. Participation is always voluntary.
SYNAPSE-MG Clinical Study
Sponsor: NMD Pharma
The SYNAPSE-MG clinical study is evaluating an investigational oral treatment for adults living with generalized myasthenia gravis (gMG). Participants may continue their current MG medications during the study, and travel reimbursement or compensation may be available for eligible participants.
Johnson & Johnson Clinical Trial
Sponsor: Johnson & Johnson
This clinical trial is currently enrolling adults with generalized myasthenia gravis (gMG). The study is evaluating two treatment approaches to help researchers better understand future treatment options.
ADAPT Forward Study
Sponsor: argenx
The ADAPT Forward Study is evaluating the safety and effectiveness of multiple treatment approaches for people living with myasthenia gravis. Adults with MG may be eligible to participate if they meet the study requirements.
PROPEL Study
Sponsor: Splash Clinical
The PROPEL Study is evaluating an investigational weekly injectable therapy (IMVT-1402) for adults with generalized myasthenia gravis. Eligible participants will continue taking their current MG medications while participating in the study.
LaGrippe Research Study
LaGrippe Research is conducting interview-based healthcare research for adults living with myasthenia gravis and family caregivers. This is a market research study—not a clinical trial—and no medications or treatments are involved. Eligible participants receive compensation for their time.
Participating in MG Research
Taking part in research is a personal decision. Clinical studies may involve different types of visits, testing, treatments, questionnaires, or other procedures depending on the study.
If you are considering participating, take time to understand what the study involves, including its purpose, eligibility requirements, potential benefits and risks, time commitment, and any costs or compensation. You can also ask the research team questions before deciding whether to participate.
Most importantly, talk with your healthcare provider before deciding whether a particular clinical trial or research opportunity is right for you.
Learn More About Clinical Trials
Not sure what participating in a clinical trial involves? These resources can help you understand the process and prepare questions to ask.
- Your Questions About Clinical Trials Answered
- Clinical Trials Q&A: What Patients, Doctors & Pharma Should Know
Disease Registries
Patient participation is also an important part of long-term research. Disease registries collect information from people living with a particular condition and can help researchers better understand the disease, identify patterns, and develop future studies.
If you’re interested in contributing to research beyond a specific clinical trial, these registries may be worth exploring:
- The Autoimmune Disease Registry (ARNet) — Supports research into autoimmune diseases, including myasthenia gravis, through the American Autoimmune Related Disease Association.
- MG Registry — Supports research specifically focused on myasthenia gravis through the Myasthenia Gravis Foundation of America.
A Note About Research Opportunities
Conquer MG shares clinical trials, research studies, and other opportunities as a resource for the MG community. We do not endorse or recommend any specific study, treatment, therapy, medication, sponsor, or research organization.
Participation in research is always voluntary. Before enrolling in a study, we encourage you to review the study information carefully and discuss the opportunity with your healthcare provider.
